Tyler Lopez is sharing what’s coming in H1 for AVITI24—new immuno-oncology and neuroscience panels, expanded sample type compatibility including suspension cells, protein customization capabilities, and a new 48-well configuration! #AVITI24InnovationRoadmap #AVITI24